American hunters skew conservative, rural, and male — all associated with increased hesitancy about or resistance to vaccines. At the same time, hunters spend more time than most people outdoors an...
Acompaña a nuestra compañera Paula Casado a conocer el hospital de Médicos Sin Fronteras que trata más mordeduras de serpiente 🐍 del mundo.
📍 En el norte de Etiopía, este centro es un referente en.
At Target Malaria, we are working to develop gene drive mosquitoes that carry a genetic modification aimed at reducing the number of malaria mosquitoes, with only four out of over 600 species of mo...
Snakebite care: assessing PANAF antivenom
Since June 2025, Doctors Without Borders has been using PANAF, a WHO pre-approved antivenom, to treat snakebite patients.
In this interview, Dr Kassaw explains how MSF is assessing the efficacy of...
Did you know that malaria can be classified as a “sleeping beast”? Dormant stages of malaria can stay in your body for a long period of time and evade treatment.
On World Malaria Day, PhD student ...
On World Chagas disease day, we look at the “sleeping beast” Chagas disease, which can evade treatment by entering a dormant stage.
Simon Feldkamp, PhD student at Swiss TPH working on Chagas diseas...
🦟 Surveiller les moustiques, c’est protéger la santé humaine.
Depuis un an, le projet EMa‑Tigre (Émergence de Maladies vectorielles liées au moustique Tigre) surveille les moustiques en France. So..
Since June 2025, MSF has been using PANAF, a WHO‑prequalified antivenom, and conducting a study to assess its effectiveness in treating snakebite envenoming. The findings of this study will be shar...
MSF has been working in West Gondar since 2003, providing specialized care for people affected by neglected tropical diseases such as snakebite envenoming and kala‑azar in Abdurafi. The Abdurafi pr...
Some diseases rarely make global headlines, yet they affect millions of lives every day. Schistosomiasis is one of them, as a neglected tropical disease (NTD) caused by parasitic worms that continu...
TOCSINS Trial : Testing an oral treatment for snakebites in the Amazon
TOCSINS (Trial of Oral Combination Therapies for Snakebite Envenoming) is a groundbreaking clinical trial led by the Centre for Snakebite Research and Interventions (CSRI) at LSTM. The project aims...
Webinário: Flebotomíneos e Leishmania: o que sabemos e como aplicar no controle da transmissão
Webinário: Flebotomíneos e Leishmania: o que sabemos e como aplicar no controle da transmissão.
A Dra. Yara é pesquisadora em saúde pública e atua no estudo das interações moleculares entre Leishm...
La mise au point de moustiques à impulsion génétique est un processus long et minutieux qui débute dans les laboratoires confinés de l'Imperial College de Londres, où l'on identifie les modificatio...
Two Decades of Human Rabies in Brazil: Epidemiological Trends, Emerging Risks & Treatment Challenges
Two Decades of Human Rabies in Brazil: Epidemiological Trends, Emerging Risks and Treatment Challenges
Presented by Dr Raquel Gomes Catozo (Virology Lab, LIMHC and São Paulo Tropical Medicine Inst...
